Claudio Simeone Selected Research

Cystectomy

9/2023	Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis.
12/2022	Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer.
6/2022	Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
5/2022	Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
1/2022	Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
1/2022	Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
1/2022	Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry.
10/2021	Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.
6/2021	Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent.
1/2021	Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio Simeone Research Topics

Disease

40	Neoplasms (Cancer) 05/2022 - 03/2002
20	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 07/2011
18	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 08/2013
16	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 04/2008
12	Carcinoma (Carcinomatosis) 02/2022 - 03/2002
11	Neoplasm Metastasis (Metastasis) 12/2022 - 03/2006
8	Non-Muscle Invasive Bladder Neoplasms 09/2023 - 12/2012
8	Kidney Neoplasms (Kidney Cancer) 04/2022 - 03/2006
8	Margins of Excision 04/2022 - 02/2014
5	Intraoperative Complications 01/2021 - 04/2015
3	Acute Kidney Injury (Acute Renal Failure) 05/2023 - 01/2021
3	Carcinoma in Situ 01/2022 - 09/2020
3	Disease Progression 01/2022 - 06/2006
3	Pathologic Constriction (Stenosis) 12/2016 - 03/2003
2	Chronic Renal Insufficiency 01/2023 - 10/2016
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2022 - 01/2022
2	Ischemia 01/2021 - 01/2018
2	Adenocarcinoma 01/2019 - 06/2010
2	Hydronephrosis 04/2015 - 04/2015
2	Carcinogenesis 01/2014 - 06/2010
2	Atrophy 06/2006 - 11/2004
1	Shock 05/2024
1	Sepsis (Septicemia) 10/2022
1	Pain (Aches) 04/2022
1	False Aneurysm (Pseudoaneurysm) 10/2021
1	Urinary Fistula 05/2021
1	Hemorrhage 01/2021
1	Urinary Calculi (Urinary Calculus) 01/2021
1	Obesity 01/2021
1	COVID-19 12/2020
1	Infections 12/2020
1	Clear-cell metastatic renal cell carcinoma 12/2020
1	Frailty 03/2020
1	Osteoporosis 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2015

Drug/Important Bio-Agent (IBA)

8	AndrogensIBA 04/2024 - 01/2016
3	CreatinineIBA 05/2023 - 01/2015
2	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 11/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 01/2020 - 08/2019
2	Hormones (Hormone)IBA 08/2018 - 12/2012
2	Hemoglobins (Hemoglobin)IBA 03/2016 - 01/2015
2	AnticoagulantsIBA 04/2015 - 04/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2015 - 04/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2014 - 07/2011
2	Choline (Choline Chloride)IBA 07/2011 - 07/2011
1	Cisplatin (Platino)FDA LinkGeneric 12/2022
1	Epithelial Cell Adhesion MoleculeIBA 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 06/2022
1	Narcotics (Narcotic Analgesics)IBA 04/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021
1	LipidsIBA 01/2021
1	PowdersIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Aligeron (AS 2)IBA 11/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	pembrolizumabIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	atezolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	fos-related antigen 1IBA 08/2019
1	Immunoglobulin M (IgM)IBA 06/2019
1	Vitamin D FDA LinkGeneric 10/2016
1	Blood Group Antigens (Blood Groups)IBA 06/2016
1	SurvivinIBA 03/2016
1	Zoledronic Acid (Zometa)FDA Link 03/2016

Therapy/Procedure

37	Nephrectomy 04/2024 - 11/2004
25	Therapeutics 04/2024 - 06/2006
18	Cystectomy 09/2023 - 03/2003
10	Prostatectomy (Retropubic Prostatectomy) 05/2021 - 07/2011
8	Nephroureterectomy 01/2022 - 11/2019
6	Length of Stay 09/2023 - 01/2018
6	Immunotherapy 11/2022 - 01/2020
6	Operative Time 04/2022 - 02/2014
6	Radiotherapy 05/2021 - 03/2002
5	Adjuvant Chemotherapy 12/2022 - 10/2018
5	Lymph Node Excision (Lymph Node Dissection) 06/2021 - 04/2015
4	Urinary Diversion (Ileal Conduit) 09/2023 - 03/2002
4	Transurethral Resection of Bladder 10/2022 - 12/2019
3	Warm Ischemia 04/2022 - 01/2021
3	Metastasectomy 08/2019 - 03/2006
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 05/2024
1	Percutaneous Nephrolithotomy 05/2024
1	Drug Therapy (Chemotherapy) 12/2022
1	Antibiotic Prophylaxis 10/2022
1	Conservative Treatment 01/2022
1	Blood Transfusion (Blood Transfusions) 10/2021
1	Operative Surgical Procedures 03/2021
1	Patient Readmission 01/2021
1	Conversion to Open Surgery 01/2021
1	Precision Medicine 12/2020
1	Neoadjuvant Therapy 05/2020
1	Robotic Surgical Procedures 01/2017
1	Minimally Invasive Surgical Procedures 12/2016
1	Replantation 12/2016